Skip to main content
. 2004 May;57(5):552–562. doi: 10.1111/j.1365-2125.2003.02062.x

Figure 2.

Figure 2

Schematic of the tolerance model used to describe the effects of ephedrine on systolic blood pressure. ka, the absorption rate constant; CL/F, the apparent oral clearance; Cp, plasma concentration; k1i, rate constant for tolerance development; ki0, rate constant for the disappearance of tolerance; Ci, hypothetical ‘inhibitor’ concentration